Implementation of Real-time ADE Surveillance and Decision Support
- Conditions
- Adverse Drug Events
- Interventions
- Behavioral: ADE alert assistant
- Registration Number
- NCT00780572
- Lead Sponsor
- VA Office of Research and Development
- Brief Summary
The purpose of this study is to determine if an electronic alerting technology improves time to intervention for possible ADEs, identify what factors affect adoption of ADE alerts, and whether there is a cost benefit associated with the alerting technology.
- Detailed Description
Inpatient adverse drug events (ADEs) continue to be a major source of morbidity and mortality despite advances in computerized drug safety measures. Reports on the ability of computerized ADE alerts to prevent and mitigate ADEs are lacking. The aims of this project are to 1) Assess organizational, social, and cognitive factors that affect adoption of real-time ADE alerting technology; 2) Analyze the effect of the ADE alerting technology on management and rate of ADEs; and 3) Estimate the cost-benefit of the ADE alerting technology. This study will use a patient randomized design of computerized real-time ADE alerts intended for primary and secondary prevention of ADEs. The ADE alerts promise to reduce mortality, morbidity, and costs due to ADEs. This study will quantify the effect of the alerts in the hands of first-year medical residents and pharmacists. The study will explore the associations of organizational and soci-cognitive barriers and facilitators with the adoption of the ADE alert technology. At the cognitive level, it will explore whether ADE Alerts change user bias in diagnosing ADEs or whether the alerts heighten sensitivity to drug problems.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 595
- All patients admitted to the SLCVAMC at time of study.
- There are no exclusions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm 1: ADE Alerts ADE alert assistant Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group
- Primary Outcome Measures
Name Time Method Time to Intervention Once an ADE Alert Has Fired in CPRS From the time an ADE alert fires in CPRS until the time action has been taken, i.e. an order placed, up to 24 hours.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
VA Health Care Salt Lake City
🇺🇸Salt Lake City, Utah, United States